FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

OBJECTIVE Our goal was to assess the sensitivity of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the detection of mucinous carcinoma and to determine the histologic features of these tumors that may affect lesion detectability. MATERIALS AND METHODS A retrospective review of all patients with mucinous carcinoma who had undergone FDG PET at our institution from 1995 through 1998 identified 25 patients with new or recurrent mucinous carcinoma at the time of PET. In 22 of these patients, tissue specimens available from either core biopsy or surgical resection allowed detailed histologic analysis. RESULTS FDG PET revealed mucinous carcinoma in only 13 (59%) of 22 patients, resulting in an unusually high percentage (41%) of false-negative results. Two histologic features were found to be predictive of FDG PET results: tumor cellularity (p = 0.011) and the amount of mucin within the tumor mass (p = 0.009). There was a positive correlation between tumor FDG uptake and cellularity but a negative correlation with the amount of mucin. CONCLUSION FDG PET is limited in the evaluation of mucinous tumors, particularly in hypocellular lesions with abundant mucin.

[1]  G. Coates,et al.  Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  R L Wahl,et al.  Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  K. Togashi,et al.  Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. , 2001, AJR. American journal of roentgenology.

[4]  K. S. Lee,et al.  Localized form of bronchioloalveolar carcinoma: FDG PET findings. , 1998, AJR. American journal of roentgenology.

[5]  M. Cohen,et al.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. , 2001, Surgery.

[6]  J Bogaert,et al.  Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[8]  J L Sunshine,et al.  Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. , 1993, Radiology.

[9]  P. Cutler,et al.  Local threshold for segmented attenuation correction of PET imaging of the thorax , 1993 .

[10]  K. Cleary,et al.  Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions. , 1991, Archives of pathology & laboratory medicine.

[11]  H. Jadvar,et al.  False-negative fluorine-18-FDG PET in metastatic carcinoid. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  F Dehdashti,et al.  Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.

[13]  W. Chapman,et al.  Staging recurrent metastatic colorectal carcinoma with PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  J. Ray,et al.  Mucinous carcinoma—Just another colon cancer? , 1993, Diseases of the colon and rectum.

[15]  J M Hoffman,et al.  Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  R P Williams,et al.  Noninvasive grading of musculoskeletal tumors using PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  M Schwaiger,et al.  Breast imaging with fluorine-18-FDG PET: quantitative image analysis. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Baldus,et al.  Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas , 1998, International journal of cancer.

[19]  O. Stål,et al.  Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  S. Takao,et al.  MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas , 1998, Pathology international.

[21]  H. Tonami,et al.  Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  B. Siegel,et al.  Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study , 2001, Annals of surgery.

[23]  N. Meyers,et al.  H = W. , 1964, Proceedings of the National Academy of Sciences of the United States of America.